article thumbnail

Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association

Circulation

The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors. Circulation, Ahead of Print.

Cancer 51
article thumbnail

Heart-related side effects of cancer treatment must be addressed as early as possible, experts say

Medical Xpress - Cardiology

However, experts in cardio-oncology from the European Society of Cardiology (ESC) emphasize that heart and cardiovascular health must be included as early as possible in the patient's cancer treatment plan to ensure the best possible outcomes.

article thumbnail

ID: 4121762 Transforming Cardio-Oncology Care with Wearable Technology – Using Smartwatches to Monitor for Arrhythmias in Vulnerable Patient Populations

HeartRhythm

Patients with CLL are at increased risk of developing atrial fibrillation (AF), however AF is a known side effect of ibrutinib therapy as well and is associated with worse outcomes. The role of wearable technology in detecting AF in cardio-oncology has not been well defined.

article thumbnail

Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower

DAIC

The emerging field of cardio-oncology is paving the way for expert, multidisciplinary heart care before, during and after cancer treatment to mitigate adverse effects on cardiovascular health.

article thumbnail

Realizing the Promise of Artificial Intelligence–Enabled Cardio-Oncology Care

Circulation: Cardiovascular Quality & Outcomes

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

article thumbnail

Burden and prognostic impact of cardiovascular disease in patients with cancer

Heart BMJ

There is need for development of a stronger evidence base to guide clinical practice in cardio-oncology. The establishment of multicentre international registries and national-level healthcare data linkage projects are important steps towards facilitating enrichment of cardio-oncology research programmes.

article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds.